Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CC-5013 (Lenalidomide) in Myelofibrosis
NCT00087672Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jul 2004
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in myelofibrosis (MF), sponsored by University of Texas MD Anderson Cancer Center. Started Jul 2004; status: completed.
02
Drugs
lenalidomide
03
Conditions
myelofibrosis (MF)
Beyond the preview
Go deeper on NCT00087672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00087672.